Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,863 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 46,863 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.66 | $45.28 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,160 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 28, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.68 | $45.44 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,152 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 27, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.27 | $42.16 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,144 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 23, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.14 | $41.12 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,136 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 22, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.10 | $40.80 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,128 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 21, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.05 | $40.40 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,120 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 20, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.41 | $43.28 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,112 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 19, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.92 | $39.36 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,104 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 16, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.37 | $42.96 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,096 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 15, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.20 | $41.60 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,088 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 14, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.68 | $45.44 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,080 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 13, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.67 | $45.36 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,072 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 12, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.25 | $42.00 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,064 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 09, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.78 | $38.24 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,056 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 08, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.50 | $36.00 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,048 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 07, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.71 | $37.68 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,040 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 06, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.60 | $36.80 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,032 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 05, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.68 | $37.44 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,024 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 02, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.75 | $38.00 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,016 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 01, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.86 | $38.88 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,008 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 30, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.79 | $38.32 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,000 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 29, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.93 | $39.44 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,992 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 28, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.91 | $39.28 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,984 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 25, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $4.94 | $49.40 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,976 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 24, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $5.12 | $51.20 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,966 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 23, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $5.01 | $50.10 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,956 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 22, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $4.74 | $47.40 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,946 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 21, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $4.79 | $47.90 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,936 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 17, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $4.61 | $46.10 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,926 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 16, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $4.23 | $42.30 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,916 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 15, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $4.14 | $41.40 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,906 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 14, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $4.03 | $40.30 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,896 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 11, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.02 | $32.16 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,886 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 10, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.01 | $32.08 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,878 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 09, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.09 | $32.72 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,870 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 08, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.14 | $33.12 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,862 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 07, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.19 | $33.52 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,854 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 04, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.23 | $33.84 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,846 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 03, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.21 | $33.68 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,838 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 02, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.39 | $35.12 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,830 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| April 01, 2025 Filed May 9, 2025 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.24 | $33.92 |
DisclosureSEC source: 0001628280-25-024353 · wk-form4_1746824660.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,822 F1 · shares: The reported Purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 31, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.29 | $34.32 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,814 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 28, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.20 | $33.60 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,806 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 27, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.20 | $33.60 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,798 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 26, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.41 | $35.28 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,790 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 25, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.45 | $35.60 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,782 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 24, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.42 | $35.36 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,774 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 21, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $4.89 | $34.23 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,766 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 20, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.07 | $35.49 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,759 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 19, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.41 | $37.87 |
DisclosureSEC source: 0001628280-25-016743 · wk-form4_1743788254.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,752 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.